InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.590 +0.070 (+4.61%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2026 Add to My Watchlist

Price and Volume

Volume	89,500
Open	1.500
Bid (Size)	1.500 (1,800)
Ask (Size)	1.590 (100)
Prev. Close	1.520
Today's Range	1.500 - 1.600
52wk Range	0.5750 - 7.980
Shares Outstanding	9,377,034
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders

June 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.

June 02, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Performance

YTD	+42.0%	+42.0%
1 Month	+112.5%	+112.5%
3 Month	+109.2%	+109.2%
6 Month	+20.5%	+20.5%
1 Year	-53.5%	-53.5%

More News

Halper Sadeh LLC is Investigating Whether RAMP, NEE, INM, D are Obtaining Fair Deals for their Shareholders

May 29, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether D, AVB, INM, EQR are Obtaining Fair Deals for their Shareholders

May 27, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SEM, WSR, INM, GDOT are Obtaining Fair Deals for their Shareholders

May 20, 2026

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of InMed Pharmaceuticals, Inc. (Nasdaq – INM)

May 19, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

INM Stock Alert: Halper Sadeh LLC is Investigating Whether InMed Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

May 19, 2026

From Halper Sadeh LLC

Via Business Wire

InMed Pharmaceuticals Amends Preferred Investment Options

April 27, 2026

Via Newsfile

Discover the top movers in Tuesday's pre-market session. ↗

March 31, 2026

Via Chartmill

Life Sciences Virtual Investor Forum Agenda Announced for December 11th

December 09, 2025

From Virtual Investor Conferences

Via GlobeNewswire

In today's session, these stocks are experiencing unusual volume. ↗

November 20, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 20, 2025

Via Benzinga

Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

November 20, 2025

Via Benzinga

What's Driving InMed's (INM) 22% After-Hours Surge? ↗

November 20, 2025

Via Benzinga

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

September 18, 2025

From Virtual Investor Conferences

Via GlobeNewswire

InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025

September 16, 2025

From Virtual Investor Conferences

Via GlobeNewswire

Life Science Virtual Investor Forum Agenda Announced for September 18th

September 16, 2025

From Virtual Investor Conferences

Via GlobeNewswire

Get insights into the top gainers and losers of Monday's after-hours session. ↗

July 14, 2025

Via Chartmill

Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗

July 04, 2025

Via Benzinga

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

June 27, 2025

Via Newsfile

InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

June 25, 2025

Via Newsfile

Here are the top movers in Tuesday's session. ↗

June 24, 2025

Via Chartmill

BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model

June 24, 2025

Via Investor Brand Network

Curious about the most active stocks on Tuesday? ↗

June 24, 2025

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

June 24, 2025

Via Chartmill

Frequently Asked Questions

Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?

Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.

What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?

InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?

The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market

What is the current price of InMed Pharmaceuticals Inc. - Common Shares?

The current price of InMed Pharmaceuticals Inc. - Common Shares is 1.590

When was InMed Pharmaceuticals Inc. - Common Shares last traded?

The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 06/03/26 04:00 PM ET

What is the market capitalization of InMed Pharmaceuticals Inc. - Common Shares?

The market capitalization of InMed Pharmaceuticals Inc. - Common Shares is 14.91M

How many shares of InMed Pharmaceuticals Inc. - Common Shares are outstanding?

InMed Pharmaceuticals Inc. - Common Shares has 15M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.